Five questions, about two minutes. Get an indicative read on where your US business sits against the new Most-Favored-Nation pricing regime: the bilateral deals, the GLOBE and GUARD Medicare models, and the tariff lever behind them.
01 Your US market position
02 Any bilateral agreement with the White House
03 Medicare Part B exposure (GLOBE)
04 Medicare Part D exposure (GUARD)
05 Orphan-drug status
MFN Exposure Check
01 / 05
Question 01
Pick one to continue
MFN Exposure Check
Your result
MFN exposure index
LowModerateHigh
Pressure-test your exposure with our senior team
This check is an orientation. The next step is a product-level read on where the MFN models actually bite for your portfolio.
Indicative self-assessment for orientation only. It is not legal, regulatory or pricing advice, and does not establish a client relationship. Scope rules for GLOBE, GUARD and GENEROUS continue to evolve.
